It is a pharma private limited company based in Nagpur, Maharashtra, India, established in 2009.
2009 | Nagpur, Maharashtra, India | ActiveOdypharm India Private Limited, a active private limited company, was established on 06 March 2009 in Nagpur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24100MH2009PTC190795. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Santosh Deshpande (Managing Director), Ulhasrao Sitaram Deshpande (Director). Past directors included Sayali Santosh Deshpande, Santosh Deshpande, Ulhasrao Sitaram Deshpande. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Block No. 101, Plot No.288, Katol Bypass Ring Road Tawakkal Layout,Wadi, Nagpur, Maharashtra, 440023.
U24100MH2009PTC190795
190795
06 March 2009
₹0.50 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Odypharm India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Santosh Deshpande | Managing Director | 06 Mar 2009 | Current |
| Ulhasrao Sitaram Deshpande | Director | 20 May 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Director | 01 Oct 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Odypharm India Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 14.09% increase. The company also saw a slight decrease in profitability, with a 1.13% decrease in profit. The company's net worth Soared by an impressive increase of 36.09%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Odypharm India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Odypharm India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Odypharm India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Odypharm India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Odypharm India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Odypharm India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity Ulhasrao Sitaram Deshpande was appointed as a Director was appointed as a Director on 20 May 2013 & has been associated with this company since 12 years 6 months . was completed.
The activity Santosh Deshpande was appointed as a Managing Director was appointed as a Managing Director on 06 Mar 2009 & has been associated with this company since 16 years 8 months . was completed.
Progress on Odypharm India Private Limited was registered on 06 Mar 2009 with Roc Mumbai & aged 16 years 8 months as per MCA records. was documented.
The CIN of Odypharm India Private Limited is U24100MH2009PTC190795.
Odypharm India Private Limited is headquartered at Block No. 101, Plot No.288, Katol Bypass Ring Road Tawakkal Layout,Wadi, Nagpur, Maharashtra, 440023.
Odypharm India Private Limited was incorporated on 06 March 2009.
The current directors of Odypharm India Private Limited are
The primary industry of Odypharm India Private Limited is Pharma.
Odypharm India Private Limited is unlisted.
The authorized capital of Odypharm India Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Odypharm India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX